首页> 外文OA文献 >MicroRNA Gene Dosage Alterations and Drug Response in Lung Cancer
【2h】

MicroRNA Gene Dosage Alterations and Drug Response in Lung Cancer

机译:肺癌中MicroRNA基因剂量的变化和药物反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chemotherapy resistance is a key contributor to the dismal prognoses for lung cancer patients. While the majority of studies have focused on sequence mutations and expression changes in protein-coding genes, recent reports have suggested that microRNA (miRNA) expression changes also play an influential role in chemotherapy response. However, the role of genetic alterations at miRNA loci in the context of chemotherapy response has yet to be investigated. In this study, we demonstrate the application of an integrative, multidimensional approach in order to identify miRNAs that are associated with chemotherapeutic resistance and sensitivity utilizing publicly available drug response, miRNA loci copy number, miRNA expression, and mRNA expression data from independent resources. By instigating a logical stepwise strategy, we have identified specific miRNAs that are associated with resistance to several chemotherapeutic agents and provide a proof of principle demonstration of how these various databases may be exploited to derive relevant pharmacogenomic results.
机译:化疗耐药是导致肺癌患者预后不良的关键因素。尽管大多数研究集中于蛋白质编码基因的序列突变和表达变化,但最近的报道表明,microRNA(miRNA)表达变化在化学疗法反应中也起着重要作用。但是,miRNA基因座上的基因改变在化学疗法反应中的作用尚待研究。在这项研究中,我们证明了整合的多维方法的应用,以便利用公开资源的药物反应,miRNA基因座拷贝数,miRNA表达和来自独立资源的mRNA表达数据来鉴定与化疗耐药性和敏感性相关的miRNA。通过采取合理的逐步策略,我们确定了与多种化学治疗剂抗性相关的特定miRNA,并提供了有关如何利用这些各种数据库来获得相关药物基因组学结果的原理性证明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号